Related Experiment Video
Updated: Jan 12, 2026

Author Spotlight: Insights and Innovations in Gene Expression Manipulation Techniques for Choroid Plexus Research
Published on: June 16, 2023
Auto-inhibition of PRC2 by the broadly expressed long isoform of AEBP2
Marlena Mucha1, Zhihao Lai2, Nicholas J McKenzie2
1Smurfit Institute of Genetics, Trinity College Dublin, Dublin, Ireland.
Abstract:
Polycomb Repressive Complex 2 (PRC2) is an essential chromatin regulator responsible for mono-, di- and tri-methylating H3K27. Control of PRC2 activity is a critical process in development and disease, yet no inhibitory cofactor has been identified in somatic cells. Here, we show that the alternative isoforms of its accessory subunit AEBP2, namely AEBP2S (short) and AEBP2L (long), perform opposite functions in modulating PRC2 activity. Contrary to prior assumptions that AEBP2 enhances PRC2 function, we find that the widely expressed AEBP2L isoform inhibits it. AEBP2L is expressed throughout embryogenesis and adulthood and inhibits PRC2 DNA binding, histone methyltransferase activity, and binding to target genes. In contrast, AEBP2S, expressed during early embryogenesis, promotes PRC2 DNA-binding activity and is essential for de novo repression of target genes during the transition from naïve to primed pluripotency. Mechanistically, through high-resolution cryo-EM and mutagenesis, we show that the recently evolved, negatively charged N-terminal region of AEBP2L inhibits PRC2. We propose a scenario in which the N-terminus of AEBP2L arose in vertebrates to restrain PRC2 activity in somatic cells.
Insights
The accessory subunit AEBP2 has two isoforms, AEBP2L and AEBP2S, which oppositely regulate Polycomb Repressive Complex 2 (PRC2) activity. AEBP2L inhibits PRC2 in somatic cells, while AEBP2S promotes it during early development.
Area of Science:
- Epigenetics
- Chromatin Biology
- Molecular Biology
Background:
- Polycomb Repressive Complex 2 (PRC2) is crucial for H3K27 methylation, a key epigenetic mark.
- PRC2 activity regulation is vital in development and disease, but inhibitory cofactors in somatic cells remain elusive.
- AEBP2 was previously assumed to enhance PRC2 function.
Purpose of the Study:
- To investigate the functional roles of alternative AEBP2 isoforms in modulating PRC2 activity.
- To identify the mechanism by which AEBP2 isoforms regulate PRC2.
- To understand the evolutionary significance of AEBP2 isoforms in vertebrate development.
Main Methods:
- High-resolution cryo-electron microscopy (cryo-EM)
- Site-directed mutagenesis
- Analysis of AEBP2 isoform expression patterns during development
Main Results:
- AEBP2 has two isoforms, AEBP2L (long) and AEBP2S (short), with opposing effects on PRC2.
- AEBP2L, widely expressed, inhibits PRC2 DNA binding and methyltransferase activity.
- AEBP2S, expressed in early embryogenesis, enhances PRC2 DNA binding for de novo gene repression.
Conclusions:
- AEBP2L acts as an inhibitory cofactor for PRC2 in somatic cells, a function potentially evolved in vertebrates.
- AEBP2S is essential for regulating pluripotency transitions during early embryonic development.
- The N-terminal region of AEBP2L is identified as the inhibitory domain of PRC2.
Related Concept Videos
Allosteric Proteins-ATCase
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...
The Unfolded Protein Response
Regulation of the Unfolded Protein Response
GPCRs Regulate Adenylyl Cylase Activity
Cell Specific Gene Expression
RNA Polymerase II Accessory Proteins

